NDC 70710-2152 – Beizray

Docetaxel Anhydrous 20 mg/mL · Injection, Solution · Intravenous

Human Prescription Drug

Product NDC70710-2152

Product details

Brand name
Beizray
Generic name
Docetaxel
Labeler
Zydus Pharmaceuticals USA Inc.
Dosage form
Injection, Solution
Route
Intravenous
Marketing category
NDA · NDA218711
Marketed since
August 28, 2025
Listing expires
December 31, 2026
Pharmacologic class
Microtubule Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Beizray →

Package NDC codes (1)

Package NDCDescriptionSince
70710-2152-1 sample1 VIAL, GLASS in 1 CARTON (70710-2152-1) / 4 mL in 1 VIAL, GLASSAug 28, 2025

Other Beizray products